CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,539
- in 2 filings, $289K under 10b5-1 plans
Net −$288,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | HASTINGS PAUL J Director | Grant or award 10b5-1 | +5,230 | 13,604 | ||
| 2024-06-12 | HASTINGS PAUL J Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +12,179 | 12,179 | ||
| 2024-06-12 | WILLIAMS KRISTEN Chief Administrative Officer | Grant or award 10b5-1 | +54,300 | 110,364 | ||
| 2024-06-12 | Brege Laura Director | Grant or award | +5,230 | 16,552 | ||
| 2024-06-12 | Brege Laura Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 | ||
| 2024-06-12 | Kronenfeld Mark A. Director | Grant or award | +5,230 | 24,902 | ||
| 2024-06-12 | Kronenfeld Mark A. Director | Grant or award · Stock Option (Right to Buy) | +12,179 | 12,179 | ||
| 2024-06-11 | SLONIN JONATHAN Chief Medical Officer | Sale 10b5-1 | −5,012 | $28.57 | $143K | 44,569.48 |
| 2024-06-03 | RIKER LAUREN Senior Vice President, Finance | Shares withheld for taxes | −1,843 | $30.89 | $57K | 20,685.34 |
| 2024-06-03 | Reinhart Charles A. III Chief Financial Officer | Shares withheld for taxes | −2,979 | $30.89 | $92K | 39,647 |
| 2024-06-03 | WILLIAMS KRISTEN Chief Administrative Officer | Shares withheld for taxes | −3,011 | $30.89 | $93K | 56,064 |
| 2024-06-03 | GAUGLER DARYL Chief Operating Officer | Shares withheld for taxes | −2,754 | $30.89 | $85K | 62,739.58 |
| 2024-06-03 | SLONIN JONATHAN Chief Medical Officer | Shares withheld for taxes | −1,615 | $30.89 | $50K | 49,581.48 |
| 2024-03-08 | PACE GARY W Director | Sale | −90,000 | $30.60 | $2.8M | 22,127 |
| 2024-03-07 | PACE GARY W Director | Sale | −28,257 | $30.81 | $871K | 112,127 |
| 2024-03-06 | PACE GARY W Director | Sale | −1,066 | $29.67 | $32K | 140,384 |
| 2024-02-05 | WILLIAMS KRISTEN Chief Administrative Officer | Grant or award | +33,700 | 59,075 | ||
| 2024-02-05 | GAUGLER DARYL Chief Operating Officer | Grant or award | +33,700 | 65,493.58 | ||
| 2024-01-03 | SLONIN JONATHAN Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-01-02 | RIKER LAUREN Senior Vice President, Finance | Shares withheld for taxes | −159 | $32.00 | $5K | 22,528.34 |
Page 8 of 9 · 161 trades